Sunworks (SUNW) Stock Price, News & Analysis

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sunworks in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SUNW shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SUNW, but not buy additional shares or sell existing shares.
View SUNW analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 1-year target prices for Sunworks' stock. Their SUNW share price targets range from $1.20 to $1.20. On average, they predict the company's stock price to reach $1.20 in the next year.
View analysts price targets for SUNW or view top-rated stocks among Wall Street analysts.

Sunworks, Inc. (NASDAQ:SUNW) released its earnings results on Thursday, November, 11th. The semiconductor company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by $0.06. The semiconductor company earned $31.22 million during the quarter. Sunworks had a negative trailing twelve-month return on equity of 127.97% and a negative net margin of 40.36%. During the same period in the prior year, the company posted ($0.17) EPS.

Sunworks shares reverse split on the morning of Friday, August 30th 2019. The 1-7 reverse split was announced on Thursday, August 29th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 29th 2019. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sunworks investors own include Advanced Micro Devices (AMD), Plug Power (PLUG), Biocept (BIOC), iBio (IBIO), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Nokia Oyj (NOK), Onconova Therapeutics (ONTX) and VBI Vaccines (VBIV).